The government has allowed the use of the low-cost steroid drug dexamethasone as an alternative to methylprednisolone to treat coronavirus patients with moderate and severe symptoms. This comes after WHO called for increase in dexamethasone production after UK clinical trials found it had life-saving potential for critically ill Covid-19 patients. It’s already used in treating lung infections.